Dr Ning Nan Wang introduces @harshamd5 to open the chronic pain session: Perioperative use of opioid in the context of Opioid Epidemic. #CASAM2023
The opioid crisis isn’t new - China probably remembers the Opium wars that helped establish a British foothold on the continent. Opioids and OUR crisis. Is what we fear the real crisis? Are opioid-related deaths due to surgical prescriptions? No, mostly due to street fentanyl.… twitter.com/i/web/status/1…
Opioid use around the time of surgery. Understanding nociception vs pain. Does eliminating opioids during surgery make a difference - no definitive conclusions. #CASAM2023
Okay, say there was value in reducing opioids - what’s in a name? Multimodal analgesia does not include complete avoidance of opioids. Removing opioids prolongs recovery. #CASAM2023
An important point - differentiating analgesics from adjuvants, and what is their overall value? Opioid free anesthesia MOVEMENT (sort of like a cult but nicer? 😉) - hype due to contextual interpretation. The puzzle pieces don’t really fit. #CASAM2023
Multiple pathways. Several bundles, which to choose? Recipes raise questions. #CASAM2023
Questioning the evidence - no clinically significant difference in PONV despite opioid group not being given antiemetics. Pain itself can cause PONV. Problems with intraoperative pain. Longer recovery. Non-inferiority vs equivalence vs superiority, oh my. Primary outcome similar,… twitter.com/i/web/status/1…
No clinical benefits with OFA. And then we consider postoperative analgesia (where #AnyAnes ceases to have impact?) Procedure specific analgesia requirements, individual variability. 3 cohorts of patient responses postoperatively: pain decreases, pain plateaus and pain increases… twitter.com/i/web/status/1…
Differences between US patients and international groups. It is perceived that OFA will translate to decreased persistent opioid use and lower long term complications. But pre- and intraoperative opioids are not associated with postoperative pain trajectory. Studying prolonged… twitter.com/i/web/status/1…
Postoperative opioid use (where problem lies?) not studied. Short follow-up durations hamstring OFA studies. Surgical opioid prescription-need and issue: barriers to guideline based prescriptions. #CASAM2023
@SQuashie presents an update on anesthesia for operative delivery. Declarations. Methodology and themes. #OAA24ASM #OBAnes
Gastric USS. Oral rehydration has benefits over NPO wrt vasopressor use. #siptilsend safe, noting some patients have increased gastric volumes irrespective of starvation status. #OAA24ASM #OBAnes
@SQuashie continues at a rapid pace. To DPE or not to DPE remains a question - 16min vs 19 min, is that 3 min clinically relevant? Esketamine for supplemental analgesia - >95% had psych effects, read @rjharrison79 editorial. #OAA24ASM #OBAnes
@Jamesocarroll presents an Update on Labour and Delivery. Disclosures #OAA24ASM #OBAnes
How the lecture was put together. Screening. Themes. How to interpret the slides. Very Ostheimer-esque @Jamesocarroll #OAA24ASM #OBAnes
@Jamesocarroll Clinical practice theme: intrathecal catheters & ADP. Intrathecal catheters: No decrease in PDPH, but reduction in EBP. 10mL intrathecal saline decreased PDPH & need for EBP. Of note, the percentage of epidurals requiring multiple attempts. #OAA24ASM #OBAnes
8am-ish in Denver and time for a much anticipated session: PDPH beyond the guidelines. Moderated by Dr Lisa Leffert, featuring @Ropivacaine, @euklaas, @sharonOzynger and @WouterSchievink at #SOAPAM2024 #OBAnes
(HT: @Ropivacaine, bless his heart, he knows I hate missing out)
Hot off the Press? August 2023! @JAMANetworkOpen with quite an illustrious team including @Ropivacaine @robin_russell1 @KalagaraHari @LimGrapes @claralexlobo @noolslucas @NarouzeMD (please tag others if you have their handles?) #SOAPAM2024 #OBAnes
Introduction, Methods and the 10 questions. #SOAPAM2024 #OBAnes
Next up at #CASAM2023 - fittingly keeping the most important academic session to last: #OBAnes @ValZaph moderating the Maternal Experience and Outcomes: Improving the care we provide. @DrWesleyEdwards
Dr Christina Lamontagne kicks off the session with: Use of Dexmedetomidine in improving maternal experience and outcomes. Nothing to disclose. Then an important disclosure: All indications discussed are OFF LABEL in Canada. Objectives. #OBAnes#CASAM2023
Why does Dr Lamontagne use a lot of dexmedetomidine (not only in #OBAnes mind)? Clinical pharmacology of dexmedetomidine (1): highly selective alpha-2 agonist; sedation WITHOUT amnesia at locus coeruleus. #CASAM2023
PPH: a focus on coagulation is kicked off by Dr Karine Doyon (a hematologist). Objectives. Canada ranked 39th in world in maternal mortality - not sure if that’s good. We’re doing better than USA. #OBAnes#CASAM2023
Causes of coagulopathy in pregnancy - Dr Doyon won’t be discussing inherited disorders. The focus will be on the acquired hemorrhagic disorders. #OBAnes#CASAM2023